T5S1607 identified as a antibacterial FtsZ inhibitor：Virtual screening combined with bioactivity evaluation for the drug discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

T5S1607 identified as a antibacterial FtsZ inhibitor：Virtual screening combined with bioactivity evaluation for the drug discovery

Published:2024-02 Issue: Volume:108 Page:108006
ISSN:1476-9271
Container-title:Computational Biology and Chemistry
language:en
Short-container-title:Computational Biology and Chemistry

Author:

Xie Zhouling,Ruan Wei,Guo Jiaojiao,Li Yan,Zhou Siqi,Zhao Jing,Wan Li,Xu Shan,Tang Qidong,Zheng Pengwu,Wang Linxiao,Zhu Wufu

Publisher

Elsevier BV

Subject

Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology

Reference43 articles.

1. Current landscape in the discovery of novel antibacterial agents;Vila;Clin. Microbiol Infect.,2020

2. Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism;Du;RSC Med. Chem.,2022

3. FtsZ inhibitors as a new genera of antibacterial agents;Tripathy;Bioorg. Chem.,2019

4. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity;Rai;Biochem J.,2008

5. FtsA is localized to the septum in an FtsZ-dependent manner;Addinall,1996

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial peptides: A promising solution to combat colistin and carbapenem resistance;Gene Reports;2024-09

2. Fused in silico and bioactivity evaluation method for drug discovery: T001-10027877 was identified as an antiproliferative agent that targets EGFRT790M/C797S/L858R and EGFRT790M/L858R;BMC Chemistry;2024-08-27

3. In silico method and bioactivity evaluation to discover novel antimicrobial agents targeting FtsZ protein: Machine learning, virtual screening and antibacterial mechanism study;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-23

4. Virtual Screening, Molecular Dynamics Simulation, and Bioactivity Assessment Validate T13074 as a Dual-Target EGFR/c-Met Inhibitor;Current Medicinal Chemistry;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3